Conference Banner

CHI's Immunogenicity and Bioassay Summit 2015


 
REASONS TO CHOOSE CHI’s IMMUNOGENICITY AND BIOASSAY SUMMIT 2015 
  • 7 FDA experts on a range of topics: Presentations, breakout discussions and a short course
  • Addresses the real challenges in immunogenicity assessment 
  • Risk assessment strategies 
  • Immunogenicity for biosimilars: from the FDA, from Europe and an industry case study
  • Models for immunogenicity prediction 
  • Impact of impurities, aggregates and SVPs  
  • Deimmunization and tolerance mechanisms: including a clinical case study
  • Advances in bioassay technologies and potency testing 
  • Bioassays assays for multiple modes of action and challenging therapeutic areas 
  • Bridging studies and assay transfer 
  • Choice of 12+ interactive breakout discussions: to help you iron out your immunogenicity and bioassay challenges
  • 4 Short courses: Focussing on assay development, risk assessment and regulatory strategy, and on bioassay design and analysis

Pre-Conference Short Courses 
November 16
  • SC1: Basics of Immunogenicity Testing
  • SC2: Challenges of Immunogenicity Assessment
    (Dinner Course) 

Dinner Short Courses
 
November 18 
  • SC3: Immunogenicity Risk Assessment & Regulatory Strategy
  • SC4: Strategic Assay Design and Analysis
 


By Series:
By Region:


Conference
& Course Catalog

CHI Catalog 


Short Course DVDs